Genetron
most comprehensive based platform and assay portfolio | Genetron
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2020
Slide
16 of 41
Related slides by other companies
AbCellera
Investor Conference
January 2024
continued focus on high value programs and strategic partnerships with our differentiated technology position in liquidity we have a long cash runway for focused investment execution completion of engine over the next years we will continue to invest in the final stage of our engine including construction commissioning of our manufacturing facility our portfolio of partnered in we anticipate partnership deals from our cell engager platform our partnership strategy is to select high value not deal volume our portfolio of internal we expect to enter clinical development in in we expect additional first in class development candidates from our ion channel platform | AbCellera
AvePoint
Investor Presentation
November 2022
why we win depth and breadth of platform comprehensive data strategy platform approach benefits | AvePoint
Affirm
Results
May 2023
platform portfolio and funding mix | Affirm
D-Wave
SPAC
February 2022
wave at a glance | D-Wave
Other recent decks by Genetron
See all presentations (5 decks)
Results
June 2022
Results
August 2021
Results
May 2021
Results
April 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io